Bafna Pharmaceuticals Ltd (BAFNAPH) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 852453, "name": "Bafna Pharma.", "stock_name": "Bafna Pharma.", "full_name": "Bafna Pharmaceuticals Ltd", "name_url": "stocks-analysis/bafna-pharma", "exchange": 1, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "317.20", "chg": 6.2, "chgp": "1.99%", "dir": 1, "prev_price": "311.00", "mcapval": "", "mcap": "Micro Cap", "scripcode": 532989, "symbol": "BAFNAPH", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE878I01022", "curr_date": "Sep 18, 03:30 PM", "curr_time": "07:31 AM", "last_traded_at": "Sep 18, 03:30 PM IST", "bse_nse_vol": "28.94 k", "exc_status": "Active", "traded_date": "Sep 18, 2026", "traded_date_str": "2026 09 18", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bafna-pharma-852453-1&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 322.5", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs3225-4197516", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4197516.png", "date": "2026-09-18 11:36:06", "description": "Surging past its previous peaks, Bafna Pharmaceuticals Ltd touched a new 52-week high of Rs 322.5 on 18 Sep 2026, marking a remarkable 146.47% gain over the past year. This milestone comes amid a sustained rally driven by a confluence of bullish technical indicators and strong price momentum." }, { "title": "Bafna Pharmaceuticals Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/bafna-pharmaceuticals-ltd-is-rated-sell-4191029", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_mojoScore_4191029.png", "date": "2026-09-12 10:10:26", "description": "Bafna Pharmaceuticals Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Bafna Pharmaceuticals Gains 2.13%: 3 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-213-3-key-factors-driving-the-weeks-momentum-4183634", "imagepath": "", "date": "2026-09-05 15:03:08", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>31 Aug:</strong> New 52-week high and upper circuit hit at Rs.304.50</p>\n <p><strong>1 Sep:</strong> All-time high reached at Rs.318</p>\n <p><strong>2 Sep:</strong> Price correction begins with a 2.00% decline</p>\n <p><strong>4 Sep:</strong> Week closes at Rs.296.60, down 1.97% on the day</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.290.40</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.296.60</div><div class=\"stat-change ..." }, { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 318", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-of-rs318-4177406", "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/BafnaPharmaceut_priceRelatedfactors_4177406.png", "date": "2026-09-01 09:45:39", "description": "From a 52-week low of Rs 95 to a fresh peak of Rs 318, Bafna Pharmaceuticals Ltd has surged over 200% in the past year, defying the broader market’s subdued performance. This remarkable rally culminated in the stock hitting a new 52-week high on 1 Sep 2026, fuelled by a confluence of strong technical signals and sustained price momentum." }, { "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.6% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4176184", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_stocks_hitting_upper_circuit_4176184.png", "date": "2026-08-31 11:00:08", "description": "At Rs 304.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.6% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares." }, { "title": "Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 303.85 on Back of Strong Technical Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-at-rs30385-4175657", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4175657.png", "date": "2026-08-31 09:49:50", "description": "From a 52-week low of Rs 95 to a fresh peak of Rs 303.85 on 31 Aug 2026, Bafna Pharmaceuticals Ltd has delivered an extraordinary 198.04% return over the past year, significantly outpacing the Sensex’s decline of 3.63%. This remarkable rally is underpinned by a broad alignment of technical indicators signalling sustained momentum." }, { "title": "Bafna Pharmaceuticals Gains 17.57%: 6 Key Factors Driving the Week’s Rally", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-gains-1757-6-key-factors-driving-the-weeks-rally-4174443", "imagepath": "", "date": "2026-08-29 15:02:58", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>24 Aug:</strong> New 52-week high (Rs.254.55) and upper circuit hit</p>\n <p><strong>25 Aug:</strong> Upper circuit hit again amid strong buying momentum (Rs.267.25)</p>\n <p><strong>26 Aug:</strong> Third consecutive upper circuit hit (Rs.280.60)</p>\n <p><strong>27 Aug:</strong> Lower circuit hit amid heavy selling pressure (Rs.271.50)</p>\n <p><strong>28 Aug:</strong> New 52-week high and upper circuit hit (Rs.291.35)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.247.00</div></d..." }, { "title": "Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 290.4", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-new-52-week-high-marking-significant-rally-4173699", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_priceRelatedfactors_4173699.png", "date": "2026-08-28 14:15:19", "description": "Surging nearly 193% over the past year, Bafna Pharmaceuticals Ltd has now touched an intraday high of Rs 290.4, closing just 1.93% shy of its 52-week peak. This remarkable price momentum unfolds amid a backdrop of strong technical signals and a market environment where the broader Sensex trades cautiously below key moving averages." }, { "title": "Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.99% Gain — Buyers Queue, Sellers Absent", "link": "https://www.marketsmojo.com/news/stocks-in-action/bafna-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-4173197", "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/BafnaPharmaceut_stocks_hitting_upper_circuit_4173197.png", "date": "2026-08-28 10:00:21", "description": "At Rs 291.35, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 28 Aug 2026, with buyers queuing and no sellers willing to part with shares." } ], "total": 385, "sid": "852453", "stock_news_url": "https://www.marketsmojo.com/news/bafna-pharmaceuticals-852453" }, "announcements": [ { "details": "Bafna Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on November 13, 2019.", "source": "NSE", "caption": "Bafna Pharmaceuticals Limited - Outcome of Board Meeting", "datetime": "14-Nov-2019" }, { "details": " <table><tr><td>The Exchange had sought clarification from Bafna Pharmaceuticals Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>", "source": "NSE", "caption": "Reply to Clarification- Financial results", "datetime": "27-Aug-2019" }, { "details": " <table><tr><td>BAFNAPHARM: Members of the Exchange are hereby informed that the trading in Equity Shares of Bafna Pharmaceuticals Limited shall be suspended w.e.f. August 26, 2019 (i.e. closing hours of trading on August 23, 2019) on account of Reduction of Share Capital. </td></tr></table>", "source": "NSE", "caption": "Suspension of trading in equity shares", "datetime": "21-Aug-2019" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Bafna Pharmaceuticals Ltd has declared <strong>6%</strong> dividend, ex-date: 19 Sep 13", "dt": "2013-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

31 Aug: New 52-week high and upper circuit hit at Rs.304.50

1 Sep: All-time high reached at Rs.318

2 Sep: Price correction begins with a 2.00% decline

4 Sep: Week closes at Rs.296.60, down 1.97% on the day

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 318

2026-09-01 09:45:39

From a 52-week low of Rs 95 to a fresh peak of Rs 318, Bafna Pharmaceuticals Ltd has surged over 200% in the past year, defying the broader market’s subdued performance. This remarkable rally culminated in the stock hitting a new 52-week high on 1 Sep 2026, fuelled by a confluence of strong technical signals and sustained price momentum.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.6% Gain — Buyers Queue, Sellers Absent

2026-08-31 11:00:08

At Rs 304.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.6% on 31 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

Bafna Pharmaceuticals Ltd Hits New 52-Week High of Rs 303.85 on Back of Strong Technical Signals

2026-08-31 09:49:50

From a 52-week low of Rs 95 to a fresh peak of Rs 303.85 on 31 Aug 2026, Bafna Pharmaceuticals Ltd has delivered an extraordinary 198.04% return over the past year, significantly outpacing the Sensex’s decline of 3.63%. This remarkable rally is underpinned by a broad alignment of technical indicators signalling sustained momentum.

Read full news article

Bafna Pharmaceuticals Gains 17.57%: 6 Key Factors Driving the Week’s Rally

2026-08-29 15:02:58

Key Events This Week

24 Aug: New 52-week high (Rs.254.55) and upper circuit hit

25 Aug: Upper circuit hit again amid strong buying momentum (Rs.267.25)

26 Aug: Third consecutive upper circuit hit (Rs.280.60)

27 Aug: Lower circuit hit amid heavy selling pressure (Rs.271.50)

28 Aug: New 52-week high and upper circuit hit (Rs.291.35)

Week Open

Rs.247.00

Read full news article

Broad-Based Technical Strength Lifts Bafna Pharmaceuticals Ltd to 52-Week High of Rs 290.4

2026-08-28 14:15:19

Surging nearly 193% over the past year, Bafna Pharmaceuticals Ltd has now touched an intraday high of Rs 290.4, closing just 1.93% shy of its 52-week peak. This remarkable price momentum unfolds amid a backdrop of strong technical signals and a market environment where the broader Sensex trades cautiously below key moving averages.

Read full news article

Bafna Pharmaceuticals Ltd Locks at Upper Circuit With 4.99% Gain — Buyers Queue, Sellers Absent

2026-08-28 10:00:21

At Rs 291.35, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bafna Pharmaceuticals Ltd locked at its upper circuit of 4.99% on 28 Aug 2026, with buyers queuing and no sellers willing to part with shares.

Read full news article

View All News